ARCHIVES

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: Three NCI Basic Science Centers Rank In Index Of Citations; Novello: Help More Smokers Quit

August 2, 1991

In Brief: Levine Leaves NIH For Pittsburgh; Fischbach Leaves Harvard For NIH; NCI Researcher Dies

June 12, 1998

IOM Appoints 17 To National Cancer Policy Board

February 7, 1997

NTP Plans Look At Radiation, Viruses, In Carcinogen Report.

July 27, 2001

DeMets Receives Lectureship On Epidemiology From NIH.

May 4, 2001

In Washington: Health Groups Urge Congress: No Immunity For Tobacco Industry; Clinton Proposes $400M Effort To End Racial Health Disparities

February 27, 1998